Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 91-100 of 9364

Page
per page
  1. G-1
    B5455 G-1
     12 Citation
    Target: GPR30
    Summary: GPR30 agonist, potent and selective
      ≥41.2 mg/mL
  2. Radotinib(IY-5511)
    B5846 Radotinib(IY-5511)
    Target: PDGFR|Bcr-Abl
    Summary: Bcr-Abl tyrosine kinase inhibitor
      ≥13.73 mg/mL
  3. MYK-461
    A8720 MYK-461
    Summary: inhibits adenosine triphosphatase activity
  4. DMH-1
    B3686 DMH-1
     2 Citation
    Target: BMP and Other Activin Receptors
    Summary: Selective BMP ALK2 receptor
      insoluble in H2O; insoluble in EtOH; ≥9.51 mg/mL
  5. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
     1 Citation
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC inhibitor
      ≥57.1 mg/mL
  6. Chlorambucil
    B3716 Chlorambucil
    Summary: nitrogen mustard alkylating agent
      insoluble in H2O; ≥12.15 mg/mL
  7. T-5224
    B4664 T-5224
     10 Citation
    Target: AP-1|MMP
    Summary: C-Fos/AP-1 inhibitor
      ≥25.88 mg/mL
  8. Bromocriptine mesylate
    B6298 Bromocriptine mesylate
    Summary: A potent, selective D2-like dopamine receptor agonist
      insoluble in H2O; insoluble in EtOH; ≥20.05 mg/mL
  9. Melittin
    B6628 Melittin
    Summary: Inhibits Gs and stimulates Gi activity
      ≥114.6 mg/mL
  10. Suramin hexasodium salt
    B6752 Suramin hexasodium salt
    Summary: DNA topoisomerase II inhibitor
      ≥71.45 mg/mL

Items 91-100 of 9364

Page
per page